June 06, 2016
Article
Side Note
Cancer-related picture books can help children better understand and face cancer.
May 26, 2016
Article
Features
Speech pathologists can help ease “chemobrain” through cognition training, and by teaching patients to compensate for deficits in memory or skills.
May 24, 2016
Article
Editor's Page
At the genomic level, we now have the tools to detect multiple mutations in the billions of DNA base pairs of cancer cells of a given person’s tumor, and from that information, to select one of several targeted drugs that may be a “match” for that tumor.
May 23, 2016
Article
Letters from Our Readers
Letters from you, our readers.
May 23, 2016
Article
Prevention
Cigarette smoking is the No. 1 risk factor for lung cancer. But there is now promising news for people who are battling the addiction.
May 20, 2016
Article
Childhood Cancer
When a bone cancer diagnosis at age 13 stopped James Ragan from playing sports, he found the art of film, which continued to play a major role in the rest of his life.
May 20, 2016
Article
House Call
Cancer care is clearly becoming more complex — and the world isn’t standing still to wait for patients or their health care professionals to catch up.
May 19, 2016
Article
Features
Cooling caps can preserve hair for patients with breast cancer undergoing chemotherapy.
May 18, 2016
Article
Features
By participating in survivorship clinical trials, those who have weathered cancer can improve quality of life — not just for themselves, but for future survivors.
May 17, 2016
Article
Features
Telling cancer stories through comics and graphic novels can be therapeutic for writers, illustrators and their audiences.
May 17, 2016
Article
Features
Men whose partners are diagnosed with cancer may need to learn new strategies to become effective caregivers.
May 16, 2016
Article
From the Chairman
When it comes to cancer treatment, why do some patients respond better than others? That’s a question researchers are working tirelessly to answer.
May 13, 2016
Article
Features
Scientists are studying exceptional responders, who benefit from cancer therapies when others don’t, to learn how to duplicate those results in broader groups of patients.